A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of Elobixibat in Patients With Chronic Idiopathic Constipation
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Elobixibat (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Acronyms ACCESS
- 24 May 2011 Results published in the American Journal of Gastroenterology.
- 17 May 2011 New trial record
- 10 May 2011 Results presented at Digestive Disease Week 2011.